Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for May 2008
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

European threat to direct-to-pharmacy controls
Commission decision could hit Spanish and UK systems..(more)

 Lipitor in decline as PCTs take control
Pfizer's flagship brand suffers as trusts flex their muscles..(more)

 Frontline yet to be convinced on reform pledges
Lord Darzi aims to ensure future changes are appropriate..(more)

 Brussels to boost Europe's R&D with public funds
European Commission readies Euro 2 billion for new ideas..(more)

 NHS behind world's first gene treatment for blindness
Procedure could pave way for a new range of eye treatments..(more)

 Latest news from Datamonitor
Product roundup..(more)

 GSK invests in science of anti-ageing
Acquires US company Sirtris for £362 million..(more)

 Calls for NHS rule change to allow co-payment
AZ's Brinsmead among those to express support for change..(more)

 Specialist nurses fear for jobs
NHS cutbacks seen as a major threat..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.